Who founded Cocrystal Pharma?

Cocrystal Pharma was founded by RAYMOND F SCHINAZI, Brian Keller, Sam Lee.

How much funding has Cocrystal Pharma raised?

Cocrystal Pharma has disclosed $23.7M raised across 8 of its 10 known rounds.

Where is Cocrystal Pharma headquartered?

Cocrystal Pharma is headquartered in Tucker, US.

Cocrystal Pharma

NASDAQ: COCP

Tucker, US · Delaware corporation · 2 known investors

Find your way into Cocrystal Pharma

Paths you didn't know you had: your email and LinkedIn already hold routes to the Cocrystal Pharma team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Cocrystal Pharma is a clinical-stage biotechnology company that discovers and develops broad-spectrum antiviral drugs targeting the replication process of viruses including influenza, coronaviruses (SARS-CoV-2, MERS), norovirus, and hepatitis C. It uses structure-based drug discovery technologies to develop treatments for serious and chronic viral diseases such as influenza, COVID-19, hepatitis C, and norovirus-caused gastroenteritis.

Biotech Healthtech

Founders & leadership

RAYMOND F SCHINAZICo-founder

Brian KellerCo-founder

Sam LeeCo-founder · President

WALT ADDISON LINSCOTT Business Operations Executive, General Counsel and Corporate Secretary2015–2017Walt Addison Linscott is an Executive Officer at Cocrystal Pharma who previously served as an Officer in the Marines and has held leadership roles in high-technology, regulated industries across international markets including Europe, the Middle East, South America, China, Africa, and India.

DOUGLAS L MAYERS Chief Medical Officer2015–2016Douglas L Mayers is Chief Medical Officer at Cocrystal Pharma, a clinical-stage biotechnology company developing antiviral drugs. He holds an MD from University of Pennsylvania Medical School and has extensive experience in drug development, oncology, and medical devices.

CURTIS DALEExecutive

JEFFREY A MECKLERChief Executive Officer and member of the Board of Directors2015–2016

GARY A WILCOX Vice Chairman of the Board of DirectorsGary Wilcox holds a Ph.D. and has held leadership roles at multiple biotechnology companies, including co-founder and CEO of Ingene, Vice Chairman and EVP of Xoma Corporation, and board member and EVP of Operations at Icos Corporation, as well as a decade-long tenure as a microbiology professor at UCLA.

Elliot M. MazaExecutive

Christian OertleExecutive

Daniel FisherExecutive

James J. Martin Co-CEO and CFOJames J. Martin is Co-Chief Executive Officer and Chief Financial Officer at Cocrystal Pharma, a clinical-stage biotechnology company developing broad-spectrum antiviral treatments. He brings experience in corporate financial and accounting management, including SEC compliance.

Investors · 2

Also in the syndicate · 2

OPKOOPKO Health

Funding

SEC filings, press & company announcements

$23.7M disclosed across 8 of 10 rounds · 2012–2026

$5MPrivate PlacementAug 2026 · 2 sources
OPKO, OPKO Health
Source ↗

▶$3MraisedMay 2017 · 3 investors · Pharmaceuticals

Rule 506(b)